Sweet
Value
Lab
Methodology
Pricing
Kiniksa Pharmaceuticals, Ltd.
KNSA
Healthcare
Biotechnology
NASDAQ
Sign in to watch
$45.75
Market Cap: $3.39B
Valuation
Financials
Forecast
Compare
Historical Price
Solvency
Dividends
Transactions
People
Dividend Discount Model
This section is coming soon.